Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Pharmaceutical Research
|
May 6, 2009
Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration
Nashwa El-Gendy, Cory Berkland
AAPS Pharmscitech
|
June 20, 2008
Niosome-encapsulated gentamicin for ophthalmic controlled delivery
Ghada Abdelbary, Nashwa El-Gendy
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
February 14, 2015
NanoCluster Itraconazole Formulations Provide a Potential Engineered Drug Particle Approach to Generate Effective Dry Powder Aerosols
Warangkana Pornputtapitak, Nashwa El-Gendy, Cory Berkland
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 4, 2011
Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols
Nashwa El-Gendy, Warangkana Pornputtapitak, Cory Berkland
Journal of Pharmaceutical Sciences
|
November 19, 2011
Nanocluster budesonide formulations enhance drug delivery through endotracheal tubes
Warangkana Pornputtapitak, Nashwa El-Gendy, Cory Berkland
Journal of Pharmaceutical Sciences
|
May 3, 2014
NanoClusters surface area allows nanoparticle dissolution with microparticle properties
Christopher Kuehl, Nashwa El-Gendy, Cory Berkland
International Journal of Pharmaceutics
|
March 11, 2010
Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent
Nashwa El-Gendy, Kristin L Aillon, Cory Berkland
Journal of Pharmaceutical Sciences
|
May 25, 2012
Development of budesonide nanocluster dry powder aerosols: preformulation
Nashwa El-Gendy, Parthiban Selvam, Pravin Soni, et al.
Journal of Pharmaceutical Sciences
|
April 28, 2012
Development of budesonide nanocluster dry powder aerosols: processing
Nashwa El-Gendy, Parthiban Selvam, Pravin Soni, et al.
Therapeutic Delivery
|
August 8, 2013
Delivery and performance of surfactant replacement therapies to treat pulmonary disorders
Nashwa El-Gendy, Anubhav Kaviratna, Cory Berkland, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Pharmaceutical Research
|
May 6, 2009
Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration
Nashwa El-Gendy, Cory Berkland
AAPS Pharmscitech
|
June 20, 2008
Niosome-encapsulated gentamicin for ophthalmic controlled delivery
Ghada Abdelbary, Nashwa El-Gendy
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
February 14, 2015
NanoCluster Itraconazole Formulations Provide a Potential Engineered Drug Particle Approach to Generate Effective Dry Powder Aerosols
Warangkana Pornputtapitak, Nashwa El-Gendy, Cory Berkland
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 4, 2011
Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols
Nashwa El-Gendy, Warangkana Pornputtapitak, Cory Berkland
Journal of Pharmaceutical Sciences
|
November 19, 2011
Nanocluster budesonide formulations enhance drug delivery through endotracheal tubes
Warangkana Pornputtapitak, Nashwa El-Gendy, Cory Berkland
Journal of Pharmaceutical Sciences
|
May 3, 2014
NanoClusters surface area allows nanoparticle dissolution with microparticle properties
Christopher Kuehl, Nashwa El-Gendy, Cory Berkland
International Journal of Pharmaceutics
|
March 11, 2010
Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent
Nashwa El-Gendy, Kristin L Aillon, Cory Berkland
Journal of Pharmaceutical Sciences
|
May 25, 2012
Development of budesonide nanocluster dry powder aerosols: preformulation
Nashwa El-Gendy, Parthiban Selvam, Pravin Soni, et al.
Journal of Pharmaceutical Sciences
|
April 28, 2012
Development of budesonide nanocluster dry powder aerosols: processing
Nashwa El-Gendy, Parthiban Selvam, Pravin Soni, et al.
Therapeutic Delivery
|
August 8, 2013
Delivery and performance of surfactant replacement therapies to treat pulmonary disorders
Nashwa El-Gendy, Anubhav Kaviratna, Cory Berkland, et al.
Page
of 3